CoChat

Near‐normalization of glycaemic control with glucagon‐like peptide‐1 receptor agonist treatment combined with exercise in patients with type 2 diabetes

Open access
Mensberg, P., Nyby, S., Jørgensen, P. G., Storgaard, H., Jensen, M. T., Sivertsen, J., Holst, J. J., Kiens, B., Richter, E. A., Knop, F. K., Vilsbøll, T. · 2017 · Diabetes, Obesity and Metabolism
Cited by 69

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Abstract

Aims: To investigate the effects of exercise in combination with a glucagon‐like peptide‐1 receptor agonist ( GLP‐1RA ), liraglutide, or placebo for the treatment of type 2 diabetes. Methods: Thirty‐three overweight, dysregulated and sedentary patients with type 2 diabetes were randomly allocated to 16 weeks of either exercise and liraglutide or exercise and placebo. Both groups had three supervised 60‐minute training sessions per week including spinning and resistance training. Results: Glycated haemoglobin ( HbA1c ) levels dropped by a mean ± standard deviation of 2.0% ± 1.2% (from 8.2% ± 1.4%) in the exercise plus liraglutide group vs 0.3% ± 0.9% (from 8.0% ± 1.2%) in the exercise plus placebo group ( P < .001), and body weight was reduced more with liraglutide (−3.4 ± 2.9 kg vs −1.6 ± 2.3 kg; P < .001). Compared with baseline, similar reductions were seen in body fat (exercise plus liraglutide: −2.5% ± 1.4% [ P < .001]; exercise plus placebo: −2.2% ± 1.9% [ P < .001]) and similar increases were observed in maximum oxygen uptake (exercise plus liraglutide: 0.5 ± 0.5 L O 2 /min [ P < .001]; exercise plus placebo: 0.4 ± 0.4 L O 2 /min [ P = .002]). Greater reductions in fasting plasma glucose (−3.4 ± 2.3 mM vs −0.3 ± 2.6 mM , P < .001) and systolic blood pressure (−5.4 ± 7.4 mm Hg vs −0.6 ± 11.1 mm Hg , P < .01) were seen with exercise plus liraglutide vs exercise plus placebo. The two groups experienced similar increases in quality of life during the intervention. Conclusions: In obese patients with type 2 diabetes, exercise combined with GLP‐1RA treatment near‐normalized HbA1c levels and caused a robust weight loss when compared with placebo. These results suggest that a combination of exercise and GLP‐1RA treatment is effective in type 2 diabetes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/dom.12797

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 19 references

Research works printed but not linked: 19

  1. 10.2337/dc16-S007 · DOI
  2. 10.1620/tjem.227.289 · DOI · Paper page
  3. George CM, 2015, Management of blood glucose with noninsulin therapies in type 2 diabetes, Am Fam Physician, 92, 27
  4. 10.2337/diab.43.7.862 · DOI · Paper page
  5. 10.1016/j.molmed.2008.01.003 · DOI · Paper page
  6. 10.1097/00005650-199206000-00002 · DOI · Paper page
  7. Bablok W, 1988, A general regression procedure for method transformation. Application of linear regression procedures for method comparison studies in clinical chemistry, Part III, J Clin Chem Clin Biochem Z Für Klin Chem Klin Biochem, 26, 783
  8. 10.1210/jc.2009-0921 · DOI · Paper page
  9. 10.2337/diab.43.4.535 · DOI · Paper page
  10. 10.1016/0167-0115(84)90005-3 · DOI
  11. 10.2337/diacare.21.12.2191 · DOI · Paper page
  12. 10.1007/s00125-012-2774-z · DOI · Paper page
  13. 10.1016/S0140-6736(10)60307-8 · DOI · Paper page
  14. 10.1038/ijo.2012.208 · DOI · Paper page
  15. 10.2337/diab.44.9.1010 · DOI · Paper page
  16. 10.1210/jc.2013-2232 · DOI · Paper page
  17. 10.1016/S0140-6736(13)62154-6 · DOI · Paper page
  18. Pessin JE, 2013, Adipokines mediate inflammation and insulin resistance, Front Endocrinol, 4, 71
  19. 10.1139/apnm-2016-0122 · DOI

Cited by

Metadata

Authors
Mensberg, P., Nyby, S., Jørgensen, P. G., Storgaard, H., Jensen, M. T., Sivertsen, J., Holst, J. J., Kiens, B., Richter, E. A., Knop, F. K., & Vilsbøll, T.
Venue
Diabetes, Obesity and Metabolism
Publisher
Wiley
Published
2016-11-04
Volume
19
Issue
2
Pages
172-180
ISSN
  • 1462-8902 (ISSN-L)
  • 1463-1326
OpenAlex
W2527559853
Cited by
69
References
19
FWCI
4.04
Type
journal article
Language
en
Open access
hybrid
Funders
  • Eli Lilly and Company
  • Gentofte Hospital
  • AstraZeneca
  • Novartis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.